We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Foreign companies seeking to market novel medical technologies in China should have an easier time, thanks to an agreement by Chinese officials to cut regulatory red tape. Read More
Foreigners can now own up to 100 percent of existing medical devicemakers in India without first getting government approval, under a carve-out of the country’s foreign direct investment policy for drugs. Read More